Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus
JAMA · 2024
DOI: 10.1001/jama.2024.5859 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Fatimah S Dawood und 2 weiteren Autor:innen. Beteiligte Einrichtung: Surveillance and Prevention Branch, Coronavirus and Other Respiratory Viruses Division, US Centers for Disease Control and Prevention, Atlanta, Georg…. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
This Viewpoint discusses recommendations from the US Centers for Disease Control and Prevention for newly licensed immunizations for respiratory syncytial virus in infants, children with high-risk conditions, and older adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Surveillance and Prevention Branch, Coronavirus and Other Respiratory Viruses Division, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Förderung
- Intramural CDC HHS
Zitieren
APA
Dawood, F. S., Payne, A. B., & McMorrow, M. L. (2024). Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus. JAMA. https://doi.org/10.1001/jama.2024.5859
Vancouver
Dawood FS, Payne AB, McMorrow ML. Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus. JAMA. 2024. doi:10.1001/jama.2024.5859
BibTeX
@article{Dawood2024,
author = {Dawood, Fatimah S and Payne, Amanda B and McMorrow, Meredith L},
title = {Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.5859}
}
EUVIMED